RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation

With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.

Create New Products Concept - Modern Keyboard with Button. Selective Focus on the Create New Products Keypad. Hand Finger Press Create New Products Keypad. 3D Render.
• Source: Shutterstock

Reckitt Benckiser is doubling its spend on OTC drug research and development as it looks to turn around this ailing part of its Health business.

Speaking as the UK-based health and hygiene player reported OTC sales down 3% in 2020, CFO Jeff Carr said RB...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation & IP

Haleon Invests In State-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By 

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By 

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.

Get To Know: UK Women’s Wellness Start-Up GP Nutrition

 
• By 

Meet UK women's health start-up GP Nutrition, run by busy working mother of four Gabriela Peacock, who says she "truly understands the needs of the women who are looking to her for help.”

More from Health

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By 

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Private Label ‘Smart Imitation’ Of National Brands’ Packaging Not So Wise In US OTC Drug Sector

 

First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By 

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.